Thierry Léveillard
About
In The Last Decade
Thierry Léveillard
112 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 3.4k
- Cellular and Molecular Neuroscience 1.3k
- Ophthalmology 1.2k
- Radiology, Nuclear Medicine and Imaging 354
- Cell Biology 319
Countries citing papers authored by Thierry Léveillard
This map shows the geographic impact of Thierry Léveillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Léveillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Léveillard more than expected).
Fields of papers citing papers by Thierry Léveillard
This network shows the impact of papers produced by Thierry Léveillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Léveillard. The network helps show where Thierry Léveillard may publish in the future.
Co-authorship network of co-authors of Thierry Léveillard
This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Léveillard. A scholar is included among the top collaborators of Thierry Léveillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Léveillard. Thierry Léveillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 14 | |
| 6 | 7 | |
| 7 | SPVN06, a Novel Mutation-Independent AAV-based Gene Therapy, Protects Cone Degeneration in a Pig Model of Retinitis Pigmentosa | 5 |
| 8 | Correlations between progression markers in rod-cone dystrophy due to mutations in RHO, PDE6A, or PDE6B. | 1 |
| 9 | A 1-Month Toxicology and Biodistribution NHP Pilot Study Evaluating a Single Subretinal Bilateral Administration of SPVN06 - A Novel AAV-Based Gene Therapy for the Treatment of Rod-Cone Dystrophies Agnostic of the Causative Mutation | 1 |
| 10 | The development of a therapy for retinitis pigmentosa based on the combined administration of the two products encoded by the nucleoredoxin like-1 gene | 1 |
| 11 | The combined administration of the two products encoded by the nucleoredoxin-like-I gene stabilizes vision in a mouse model of retinitis pigmentosa | 1 |
| 12 | Knowledge Base for sensory systems for biologists and clinicians | 1 |
| 13 | The thioredoxin RdCVFL protects against photo-oxidative retinal damage | 1 |
| 14 | AAV-mediated Delivery of Rod-derived Cone Viability Factor in a Mouse Model of Retinal Degeneration | 1 |
| 15 | 149 | |
| 16 | 30 | |
| 17 | 1 | |
| 18 | 26 | |
| 19 | 96 | |
| 20 | 46 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.